These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30836232)

  • 1. Changes in Persistent Asthma Care and Outcomes From 2006 to 2016 in France.
    Belhassen M; Nolin M; Nibber A; Ginoux M; Devouassoux G; Van Ganse E
    J Allergy Clin Immunol Pract; 2019; 7(6):1858-1867. PubMed ID: 30836232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH; Dean J; Zhang J; Duh MS; Gorsh B; Lefebvre P
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study.
    Chen HC; Huang CD; Chang E; Kuo HP
    BMC Pulm Med; 2016 Jan; 16():3. PubMed ID: 26747278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland.
    Jahnz-Różyk K; Lis J; Warchoł M; Kucharczyk A
    BMC Pulm Med; 2018 Mar; 18(1):48. PubMed ID: 29548318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization in infants and toddlers with asthma-like symptoms.
    Levine H; Leventer-Roberts M; Hoshen M; Mei-Zahav M; Balicer R; Blau H
    Pediatr Pulmonol; 2019 Oct; 54(10):1567-1577. PubMed ID: 31298808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
    Murray CS; Thomas M; Richardson K; Price DB; Turner SW
    J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma Severity in patients initiating controller monotherapy versus combination therapy.
    Diette GB; Fuhlbrigge AL; Allen-Ramey F; Hopper A; Sajjan SG; Markson LE
    J Asthma; 2011 Apr; 48(3):304-10. PubMed ID: 21391882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
    Balkrishnan R; Nelsen LM; Kulkarni AS; Pleasants RA; Whitmire JT; Schechter MS
    J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of Asthma Controller Therapy Before Admission to the Hospital.
    Belhassen M; Langlois C; Laforest L; Dima AL; Ginoux M; Sadatsafavi M; Van Ganse E
    J Allergy Clin Immunol Pract; 2016; 4(5):877-83. PubMed ID: 27452886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital.
    Yanagawa H; Shiraga M; Nakamura Y; Azuma M; Yoneda K; Ogawa H; Kitamuro C; Maeda K; Miki M; Matsumori Y; Sugita A; Hashimoto S; Hara C; Tani K; Sone S
    J Med Invest; 2003 Feb; 50(1-2):72-7. PubMed ID: 12630571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of asthma control by inhaled corticosteroids in general practice in Thailand.
    Boonsawat W; Boonsawat W; Thinkhamrop B
    Asian Pac J Allergy Immunol; 2015 Mar; 33(1):21-5. PubMed ID: 25840630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.